|Articles|November 1, 2012
- Pharmaceutical Executive-11-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - November 2012
Pharm Exec's 2013 Pipeline Report
Advertisement
Articles in this issue
almost 13 years ago
Europe's Trust Gapalmost 13 years ago
Who Pays for Specialty Medicines?almost 13 years ago
OTC Crunch Time in Californiaalmost 13 years ago
Prix Galien: Night at the Museumalmost 13 years ago
Real World Insightsalmost 13 years ago
Simple Questions for Spainalmost 13 years ago
Market Access Roadmapalmost 13 years ago
Pharm Exec's 2013 Pipeline Reportalmost 13 years ago
Country Report: Czech RepublicNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
2
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
3
The Evolving Landscape in Psychiatry: Challenges and Opportunities for Biopharma
4
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda
5
